Anpario says premium products boost profit as revenue rises 7%
Anpario reported revenue up 7% to £24.3m, with growth led by IMEA and the Americas while Asia declined due to toxin binder weakness. Adjusted EBITDA rose 22% and EPS increased 30%; H2 profit expectations remain unchanged despite a softer start.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.